NO20026177L - Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel - Google Patents
Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middelInfo
- Publication number
- NO20026177L NO20026177L NO20026177A NO20026177A NO20026177L NO 20026177 L NO20026177 L NO 20026177L NO 20026177 A NO20026177 A NO 20026177A NO 20026177 A NO20026177 A NO 20026177A NO 20026177 L NO20026177 L NO 20026177L
- Authority
- NO
- Norway
- Prior art keywords
- optionally
- reducing agent
- beta blocker
- new formulation
- cholesterol reducing
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
- 239000002876 beta blocker Substances 0.000 title 1
- 229940097320 beta blocking agent Drugs 0.000 title 1
- 239000003638 chemical reducing agent Substances 0.000 title 1
- 235000012000 cholesterol Nutrition 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002354A SE0002354D0 (sv) | 2000-06-22 | 2000-06-22 | New formulation |
PCT/SE2001/001380 WO2001097751A2 (en) | 2000-06-22 | 2001-06-15 | New formulation comprising a betablocker and optionally a cholesterol-lowering agent |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20026177D0 NO20026177D0 (no) | 2002-12-20 |
NO20026177L true NO20026177L (no) | 2002-12-20 |
Family
ID=20280209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20026177A NO20026177L (no) | 2000-06-22 | 2002-12-20 | Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel |
Country Status (28)
Country | Link |
---|---|
US (2) | US20030191177A1 (sk) |
EP (1) | EP1296716B1 (sk) |
JP (1) | JP2003535875A (sk) |
KR (1) | KR20030010750A (sk) |
CN (1) | CN1437484A (sk) |
AR (1) | AR028699A1 (sk) |
AT (1) | ATE344675T1 (sk) |
AU (1) | AU2001274766A1 (sk) |
BG (1) | BG107373A (sk) |
BR (1) | BR0111790A (sk) |
CA (1) | CA2411100A1 (sk) |
CZ (1) | CZ20024181A3 (sk) |
DE (1) | DE60124400T2 (sk) |
EE (1) | EE200200703A (sk) |
ES (1) | ES2274892T3 (sk) |
HK (1) | HK1054508A1 (sk) |
HU (1) | HUP0302371A3 (sk) |
IL (1) | IL153245A0 (sk) |
IS (1) | IS6653A (sk) |
MX (1) | MXPA02012957A (sk) |
NO (1) | NO20026177L (sk) |
NZ (1) | NZ523188A (sk) |
PL (1) | PL360484A1 (sk) |
RU (1) | RU2271802C2 (sk) |
SE (1) | SE0002354D0 (sk) |
SK (1) | SK18072002A3 (sk) |
WO (1) | WO2001097751A2 (sk) |
ZA (1) | ZA200209908B (sk) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8415364B2 (en) | 2003-11-26 | 2013-04-09 | Duke University | Method of preventing or treating glaucoma |
KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 a 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
KR100836321B1 (ko) | 2006-10-31 | 2008-06-09 | 현대자동차주식회사 | 차량용 모니터 장치 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175187A (en) * | 1989-03-06 | 1992-12-29 | Soorianarain Baligadoo | Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof |
US5455269A (en) * | 1989-03-06 | 1995-10-03 | Baligadoo; Soorianarain | Synergistic compositions of amiodarone and beta blockers |
DE69212646T2 (de) * | 1991-03-18 | 1997-03-13 | Sepracor Inc | Zubereitung und verfahren enthaltend optisch reines s-metoprolol |
JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
NO177455C (no) * | 1993-06-04 | 1995-09-20 | Gerrit Elmenhorst | Anordning ved apparat for fremstilling av brannslukkende skum |
CA2251972A1 (en) * | 1996-04-17 | 1997-10-23 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
SE9602762D0 (sv) * | 1996-07-12 | 1996-07-12 | Astra Ab | Carton and blank for forming the same |
US5998458A (en) * | 1997-06-25 | 1999-12-07 | University Technology Corporation | Method of treating heart failure |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. | |
EP1354604A1 (en) * | 1998-12-23 | 2003-10-22 | G.D. Searle LLC. | Combinations for cardiovascular indications |
-
2000
- 2000-06-22 SE SE0002354A patent/SE0002354D0/xx unknown
-
2001
- 2001-06-11 AR ARP010102759A patent/AR028699A1/es not_active Application Discontinuation
- 2001-06-15 BR BR0111790-4A patent/BR0111790A/pt not_active IP Right Cessation
- 2001-06-15 AU AU2001274766A patent/AU2001274766A1/en not_active Abandoned
- 2001-06-15 EE EEP200200703A patent/EE200200703A/xx unknown
- 2001-06-15 CN CN01811540A patent/CN1437484A/zh active Pending
- 2001-06-15 SK SK1807-2002A patent/SK18072002A3/sk unknown
- 2001-06-15 ES ES01941409T patent/ES2274892T3/es not_active Expired - Lifetime
- 2001-06-15 EP EP01941409A patent/EP1296716B1/en not_active Expired - Lifetime
- 2001-06-15 MX MXPA02012957A patent/MXPA02012957A/es unknown
- 2001-06-15 RU RU2002133205/15A patent/RU2271802C2/ru not_active IP Right Cessation
- 2001-06-15 NZ NZ523188A patent/NZ523188A/en unknown
- 2001-06-15 JP JP2002503228A patent/JP2003535875A/ja active Pending
- 2001-06-15 DE DE60124400T patent/DE60124400T2/de not_active Expired - Fee Related
- 2001-06-15 HU HU0302371A patent/HUP0302371A3/hu unknown
- 2001-06-15 PL PL36048401A patent/PL360484A1/xx not_active Application Discontinuation
- 2001-06-15 US US10/311,201 patent/US20030191177A1/en not_active Abandoned
- 2001-06-15 WO PCT/SE2001/001380 patent/WO2001097751A2/en not_active Application Discontinuation
- 2001-06-15 CZ CZ20024181A patent/CZ20024181A3/cs unknown
- 2001-06-15 CA CA002411100A patent/CA2411100A1/en not_active Abandoned
- 2001-06-15 KR KR1020027017474A patent/KR20030010750A/ko not_active Application Discontinuation
- 2001-06-15 IL IL15324501A patent/IL153245A0/xx unknown
- 2001-06-15 AT AT01941409T patent/ATE344675T1/de not_active IP Right Cessation
-
2002
- 2002-12-05 ZA ZA200209908A patent/ZA200209908B/en unknown
- 2002-12-11 BG BG107373A patent/BG107373A/bg unknown
- 2002-12-11 IS IS6653A patent/IS6653A/is unknown
- 2002-12-20 NO NO20026177A patent/NO20026177L/no not_active Application Discontinuation
-
2003
- 2003-09-22 HK HK03106811.1A patent/HK1054508A1/zh unknown
-
2006
- 2006-04-19 US US11/407,505 patent/US20060252814A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030191177A1 (en) | 2003-10-09 |
RU2271802C2 (ru) | 2006-03-20 |
SK18072002A3 (sk) | 2003-08-05 |
ES2274892T3 (es) | 2007-06-01 |
HK1054508A1 (zh) | 2003-12-05 |
EP1296716B1 (en) | 2006-11-08 |
NO20026177D0 (no) | 2002-12-20 |
WO2001097751A2 (en) | 2001-12-27 |
NZ523188A (en) | 2006-06-30 |
DE60124400T2 (de) | 2007-10-31 |
KR20030010750A (ko) | 2003-02-05 |
ZA200209908B (en) | 2004-03-05 |
WO2001097751A3 (en) | 2002-03-28 |
AR028699A1 (es) | 2003-05-21 |
IL153245A0 (en) | 2003-07-06 |
JP2003535875A (ja) | 2003-12-02 |
MXPA02012957A (es) | 2003-05-15 |
PL360484A1 (en) | 2004-09-06 |
EP1296716A2 (en) | 2003-04-02 |
ATE344675T1 (de) | 2006-11-15 |
CZ20024181A3 (cs) | 2003-04-16 |
HUP0302371A2 (hu) | 2003-11-28 |
BG107373A (bg) | 2003-09-30 |
CA2411100A1 (en) | 2001-12-27 |
DE60124400D1 (de) | 2006-12-21 |
EE200200703A (et) | 2004-08-16 |
SE0002354D0 (sv) | 2000-06-22 |
CN1437484A (zh) | 2003-08-20 |
US20060252814A1 (en) | 2006-11-09 |
IS6653A (is) | 2002-12-11 |
AU2001274766A1 (en) | 2002-01-02 |
HUP0302371A3 (en) | 2007-03-28 |
BR0111790A (pt) | 2003-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200241A (et) | Suhkurtõvevastane preparaat ja meetod | |
DK1216247T3 (da) | Imidazoimidazoler og triazoler som anti-inflammatoriske midler | |
NL1016224A1 (nl) | Foto-basevormend middel en foto-zuurvormend middel bevattende foto- etssamenstelling. | |
DK1278763T3 (da) | 3-Nitrogen-6,7-dioxygensteroider og anvendelser relateret dertil | |
NO20015931D0 (no) | Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin | |
DK1112003T3 (da) | Ny sammensætning og anvendelse | |
DE60026278D1 (de) | Anzeigevorrichtung und herstellungsverfahren | |
DK1173434T3 (da) | Thiazolidindionderivat og dets anvendelse som antidiabetisk middel | |
NO20025158D0 (no) | Lipidpreparat og anvendelse derav | |
AU2001276149A1 (en) | Cleaning and disinfecting agent | |
NO20030759L (no) | 10-aryl-11-HBENZO(b)fluorenderivater og analoger for medisinsk anvendelse | |
NO20005763L (no) | DHEA-sammensetning og fremgangsmåte | |
AU4427201A (en) | Noise-abatement structure and its constituting elements | |
NO20026177L (no) | Ny formulering omfattende en betablokker og eventuelt et kolesterolreduserende middel | |
GB0020427D0 (en) | Moem device and fabrication method | |
EE04659B1 (et) | Kolesterooli alandava agensi kasutamine | |
NO20023144L (no) | Et kompleks som omfatter OCIF og polysakkarid | |
DK1173436T3 (da) | Thiazolidindionderivat og anvendelse deraf som antidiabetikum | |
NO20022438L (no) | Tampong med dekke og ikke-ionisk surfaktant | |
DE50106974D1 (de) | Aufbereitungs- und applikationsvorrichtung für implantatmaterialien | |
DK1173437T3 (da) | Thiazolidinindionderivat og dets anvendelse som antidiabetisk middel | |
DK1230227T3 (da) | Benzoxa- og benzthiazolylsulfamater og anvendelse deraf som steroid-sulfataseinhibitorer | |
DE60109637D1 (de) | Dispenser für klebeband, korrekturband und ähnlichem | |
PT1404663E (pt) | Eurotinonas e seus derivados processo para a sua preparacao e sua utilizacao | |
DK1325000T3 (da) | Thiazoldiendionderivat og dets anvendelse som antidiabetisk middel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |